Last Price
6.53
Today's Change
-0.58 (8.15%)
Day's Change
6.48 - 7.11
Trading Volume
907,091
Overview
Market Cap
236 Million
Shares Outstanding
36 Million
Avg Volume
791,875
Avg Price (50 Days)
9.52
Avg Price (200 Days)
10.34
PE Ratio
-1.62
EPS
-4.02
Earnings Announcement
03-Mar-2025
Previous Close
7.11
Open
7.02
Day's Range
6.48 - 7.11
Year Range
3.61 - 22.74
Trading Volume
907,091
Price Change Highlight
1 Day Change
-8.16%
5 Day Change
-20.75%
1 Month Change
-43.27%
3 Month Change
12.98%
6 Month Change
-48.90%
Ytd Change
-55.49%
1 Year Change
-30.01%
3 Year Change
-44.33%
5 Year Change
-61.59%
10 Year Change
-61.59%
Max Change
-61.59%
News and Blogs
No result.
Company Profile
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in oncogenic signaling in multiple cancers. The company was incorporated in 2017 and is headquartered in Redwood City, California.
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
12
Latest Videos
Apps
Top Articles
1
CEO Morning Brief
US Ordered TSMC to Halt Shipments of Chips for AI to China — Reuters
2
3
CEO Morning Brief
Dogecoin Outperforms Bitcoin as Trump Spurs Crypto Speculation
4
CEO Morning Brief
5
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
